Sunil Healthcare Ltd.

As of June 30, 2026, Sunil Healthcare Ltd. carries a market capitalization of 687.07M, placing it among publicly traded companies globally. Its enterprise value stands at 687.07M, reflecting the total theoretical takeover cost after accounting for cash holdings and debt obligations.

As of June 30, 2026, Sunil Healthcare Ltd. has 10.25M shares outstanding.

As of June 30, 2026, Sunil Healthcare Ltd. trades at a trailing price-to-earnings ratio of 19.32.

As of June 30, 2026, Sunil Healthcare Ltd. trades at an EV/EBITDA multiple of 5.59 - the valuation measure that neutralizes differences in capital structure, tax rates, and depreciation policy, making it the standard yardstick for comparing companies across an industry. The EV/Sales ratio of 0.82 reflects the premium investors pay for the company's revenue stream, a useful check when earnings are depressed or negative. Its EV/EBIT multiple of 11.33 values the business against core operating earnings after depreciation, a stricter test than EV/EBITDA for capital-intensive businesses. These enterprise value multiples are built on an enterprise value of 687.07M versus a market cap of 687.07M, with the gap driven by net debt and cash on the balance sheet.

These figures are as of June 30, 2026.

These figures cover the twelve months ended June 30, 2026. The company generates approximately 5.27M in revenue per employee across its workforce of 159.50, a quick read on workforce productivity versus industry peers.

Over the twelve months ended June 30, 2026, Sunil Healthcare Ltd. recorded an income tax benefit of -21.62M rather than an expense, typically from losses, carryforwards, or the release of a tax provision. Taxes are levied on pretax income of 13.99M, leaving 35.61M in net income after tax - the gap is what shifts in the tax rate do to reported earnings and EPS.

As of the close on October 21, 2026, Sunil Healthcare Ltd.'s stock has declined approximately 1.16% over the past 52 weeks. The 50-day moving average sits at 72.20, while the 200-day moving average is 67.89.

Over the twelve months ended June 30, 2026, Sunil Healthcare Ltd. generated 840.63M in revenue and converted that into 35.61M in net income, yielding earnings per share of 3.47. EBITDA reached 122.97M, while operating income came in at 61.82M.

Over the twelve months ended June 30, 2026, Sunil Healthcare Ltd. posted a gross margin of 63.80, reflecting its pricing power and cost economics. The operating margin of 7.35 and net profit margin of 4.24 provide insight into operational efficiency.